Falls remain one of the leading causes of injury-related death and disability in adults over 65, yet decades of prevention campaigns have barely moved the needle on population-level outcomes. A framework published in The Lancet Healthy Longevity challenges a foundational assumption in geriatric medicine: that fall prevention is primarily about avoiding falls in the first place. By expanding the conceptual lens to include what happens during and after a fall, this perspective may fundamentally reshape how clinicians, researchers, and public health planners approach mobility in aging populations.
The proposed falls resilience framework organizes fall-related risk not as a binary event but across a continuum of three functional mobility strata: full community ambulation, limited community ambulation, and indoor ambulation. Within each stratum, the framework maps distinct stressors and challenges, then applies a three-phase resilience model — resisting destabilizing forces before a fall, minimizing injury severity when a fall occurs, and restoring mobility and function in the recovery phase. This tripartite structure treats resilience as a measurable, modifiable property rather than an abstract quality, which opens the door to targeted intervention design at each stage.
The paradigm shift here carries real clinical weight. Conventional fall-prevention metrics overwhelmingly focus on fall incidence rates, which can obscure meaningful improvements in injury severity, recovery speed, or post-fall psychological outcomes like fear of falling. The resilience model implicitly validates interventions — hip protectors, post-fall rehabilitation protocols, even flooring design — that reduce harm without necessarily reducing fall frequency. Its chief limitation is that it remains a conceptual framework, not yet validated against longitudinal outcome data. Additionally, as a Personal View piece rather than a systematic review or trial, its practical implementation pathways still require operationalization. Nonetheless, for a field in which randomized prevention trials have repeatedly disappointed, this framework represents a genuinely useful conceptual reorientation rather than mere incremental refinement.
